Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Change in Accured Expenses (2016 - 2026)

Dexcom has reported Change in Accured Expenses over the past 17 years, most recently at $145.1 million for Q1 2026.

  • Quarterly Change in Accured Expenses rose 24283.33% to $145.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $492.7 million through Mar 2026, up 492600.0% year-over-year, with the annual reading at $347.0 million for FY2025, 678.33% up from the prior year.
  • Change in Accured Expenses was $145.1 million for Q1 2026 at Dexcom, up from -$10.1 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $341.8 million in Q3 2025 and troughed at -$60.7 million in Q1 2024.
  • The 5-year median for Change in Accured Expenses is $9.4 million (2022), against an average of $45.0 million.
  • Year-over-year, Change in Accured Expenses tumbled 334.88% in 2025 and then surged 24283.33% in 2026.
  • A 5-year view of Change in Accured Expenses shows it stood at $123.8 million in 2022, then plummeted by 83.36% to $20.6 million in 2023, then crashed by 79.13% to $4.3 million in 2024, then crashed by 334.88% to -$10.1 million in 2025, then soared by 1536.63% to $145.1 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Change in Accured Expenses are $145.1 million (Q1 2026), -$10.1 million (Q4 2025), and $341.8 million (Q3 2025).